Microbiome Therapeutics and Recurrent Clostridioides difficile: Where Do We Go From Here?

Sunday, October 23, 2022

8:00 pm – 9:30 pm  ET



[italic]Clostridioides difficile[/italic] can cause a serious infection of the lower intestine, resulting in significant morbidity and sometimes death. The primary risk factor for [italic]C difficile[/italic] infection (CDI) is exposure to broad-spectrum antibiotics, which disrupt the normal composition and function of the gut microbiome. Antibiotics for CDI treatment do not kill bacterial spores, and recurrence is common. Restoring a healthy gut microbiome is therefore often critical for achieving a durable clinical response. In this live CME event, three clinician experts will review treatments for recurrent CDI that target the gut microbiome, including fecal microbiota transplantation and emerging live biopharmaceutical products. Faculty will discuss these therapies in the context of interactive patient cases; audience participation will be encouraged through a live Q&A.




This activity is intended for gastroenterologists, infectious disease specialists, and primary care physicians.


The goal of this activity is to provide live education on the latest data and recommendations for microbiome therapeutics and where they fit into the treatment of recurrent [italic]C difficile[/italic].


Upon completion of this activity, participants will: Have increased knowledge regarding the [LIST][ITEM]Key data for microbiome-directed treatments used in the management of recurrent CDI [ITEM]Role of the gut microbiome in recurrent CDI[/LIST] Have greater competence related to [LIST][ITEM]Management of patients with recurrent CDI[/LIST]


[JALOGO] [MEDSCAPE] In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.5 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Pharmacists[/bold] Medscape designates this continuing education activity for 1.50 contact hour(s) (0.150 CEUs) (Universal Activity Number: JA0007105-0000-22-255-L01-P).

The Westin Charlotte

601 S College Street 
Charlotte, North Carolina, 28202
United States